Perrigo EBITDA Margin 2012-2025 | PRGO
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Perrigo (PRGO) over the last 10 years. The current EBITDA margin for Perrigo as of December 31, 2025 is .
| Perrigo EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-12-31 | $4.25B | $-0.78B | -18.25% |
| 2025-09-30 | $4.28B | $0.63B | 14.60% |
| 2025-06-30 | $4.33B | $0.63B | 14.52% |
| 2025-03-31 | $4.34B | $0.55B | 12.68% |
| 2024-12-31 | $4.37B | $0.45B | 10.24% |
| 2024-09-30 | $4.39B | $0.32B | 7.22% |
| 2024-06-30 | $4.43B | $0.31B | 6.95% |
| 2024-03-31 | $4.56B | $0.40B | 8.85% |
| 2023-12-31 | $4.66B | $0.51B | 11.04% |
| 2023-09-30 | $4.65B | $0.57B | 12.31% |
| 2023-06-30 | $4.63B | $0.54B | 11.71% |
| 2023-03-31 | $4.56B | $0.46B | 10.18% |
| 2022-12-31 | $4.45B | $0.42B | 9.37% |
| 2022-09-30 | $4.40B | $0.41B | 9.22% |
| 2022-06-30 | $4.35B | $0.79B | 18.25% |
| 2022-03-31 | $4.20B | $0.67B | 15.89% |
| 2021-12-31 | $4.14B | $0.72B | 17.35% |
| 2021-09-30 | $4.09B | $0.74B | 18.01% |
| 2021-06-30 | $4.05B | $0.40B | 9.91% |
| 2021-03-31 | $4.02B | $0.61B | 15.19% |
| 2020-12-31 | $4.09B | $0.65B | 15.85% |
| 2020-09-30 | $3.39B | $0.58B | 16.99% |
| 2020-06-30 | $3.58B | $0.56B | 15.57% |
| 2020-03-31 | $3.78B | $0.55B | 14.53% |
| 2019-12-31 | $3.87B | $0.57B | 14.65% |
| 2019-09-30 | $4.71B | $0.71B | 15.01% |
| 2019-06-30 | $4.65B | $0.53B | 11.46% |
| 2019-03-31 | $4.69B | $0.59B | 12.48% |
| 2018-12-31 | $4.73B | $0.65B | 13.78% |
| 2018-09-30 | $4.82B | $0.71B | 14.80% |
| 2018-06-30 | $4.92B | $1.00B | 20.32% |
| 2018-03-31 | $4.97B | $1.05B | 21.19% |
| 2017-12-31 | $4.95B | $1.02B | 20.64% |
| 2017-09-30 | $4.99B | $0.39B | 7.79% |
| 2017-06-30 | $5.03B | $-1.24B | -24.70% |
| 2017-03-31 | $5.13B | $-1.21B | -23.54% |
| 2016-12-31 | $5.28B | $-1.57B | -29.69% |
| 2016-09-30 | $2.93B | $-1.77B | -60.30% |
| 2016-06-30 | $2.94B | $-0.13B | -4.46% |
| 2015-12-31 | $1.22B | $-0.04B | -3.62% |
| 2015-09-30 | $3.31B | $1.72B | 51.87% |
| 2014-12-31 | $3.03B | $1.68B | 55.38% |
| 2014-09-30 | $2.94B | $1.52B | 51.79% |
| 2013-12-31 | $2.83B | $1.51B | 53.43% |
| 2013-09-30 | $2.74B | $1.39B | 50.84% |
| 2012-12-31 | $2.43B | $1.33B | 54.50% |
| 2012-09-30 | $2.39B | $1.28B | 53.48% |
| 2011-12-31 | $2.26B | $1.17B | 51.97% |
| 2011-09-30 | $2.14B | $1.05B | 48.95% |
| 2010-12-31 | $1.90B | $1.00B | 52.56% |
| 2010-09-30 | $1.76B | $0.85B | 48.44% |
| 2009-12-31 | $1.62B | $0.81B | 50.06% |
| 2009-09-30 | $1.57B | $0.76B | 48.63% |
| 2008-12-31 | $1.47B | $0.73B | 49.39% |
| 2008-09-30 | $1.37B | $0.62B | 45.48% |
| 2007-12-31 | $1.18B | $0.57B | 48.56% |
| 2007-09-30 | $1.12B | $0.51B | 45.43% |
| 2006-12-31 | $1.04B | $0.48B | 46.40% |
| 2001-09-30 | $0.60B | $0.06B | 9.53% |
| 2001-03-31 | $0.72B | $0.03B | 4.01% |
| 2000-12-31 | $0.72B | $0.03B | 3.49% |
| 2000-09-30 | $0.72B | $0.04B | 6.08% |
| 2000-06-30 | $0.74B | $0.05B | 6.07% |
| 2000-03-31 | $0.78B | $0.06B | 7.57% |
| 1999-12-31 | $0.85B | $0.07B | 8.05% |
| 1999-09-30 | $0.87B | $0.06B | 7.21% |
| 1999-06-30 | $0.88B | $0.02B | 2.74% |
| 1999-03-31 | $0.90B | $0.03B | 3.32% |
| 1998-12-31 | $0.88B | $0.03B | 3.88% |
| 1998-09-30 | $0.89B | $0.05B | 5.27% |
| 1998-06-30 | $0.90B | $0.09B | 9.52% |
| 1998-03-31 | $0.89B | $0.10B | 11.07% |
| 1997-12-31 | $0.88B | $0.10B | 11.64% |
| 1997-09-30 | $0.86B | $0.10B | 11.79% |
| 1997-06-30 | $0.85B | $0.10B | 11.72% |
| 1997-03-31 | $0.83B | $0.12B | 14.06% |
| 1996-12-31 | $0.81B | $0.09B | 11.41% |
| 1996-09-30 | $0.79B | $0.08B | 10.57% |
| 1996-06-30 | $0.78B | $0.11B | 13.75% |
| 1996-03-31 | $0.78B | $0.08B | 9.92% |
| 1995-12-31 | $0.77B | $0.08B | 10.07% |
| 1995-09-30 | $0.74B | $0.08B | 10.15% |
| 1995-06-30 | $0.72B | $0.08B | 10.46% |
| 1995-03-31 | $0.70B | $0.08B | 11.98% |
| 1994-12-31 | $0.68B | $0.09B | 12.65% |
| 1994-09-30 | $0.68B | $0.09B | 13.25% |
| 1994-06-30 | $0.67B | $0.09B | 13.45% |
| 1994-03-31 | $0.66B | $0.09B | 13.57% |
| 1993-12-31 | $0.63B | $0.09B | 13.56% |
| 1993-09-30 | $0.60B | $0.08B | 13.31% |
| 1993-06-30 | $0.57B | $0.07B | 12.78% |
| 1993-03-31 | $0.54B | $0.16B | 30.65% |
| 1992-12-31 | $0.51B | $0.16B | 30.93% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.001B | $4.373B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.936B | 21.88 |
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Stryker (SYK) | United States | $140.083B | 26.86 |
| Medtronic (MDT) | Ireland | $127.548B | 17.67 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Koninklijke Philips (PHG) | Netherlands | $30.091B | 17.86 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.115B | 11.76 |
| Insulet (PODD) | United States | $17.076B | 53.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.921B | 25.86 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.160B | 14.91 |
| Haemonetics (HAE) | United States | $2.684B | 11.74 |
| Neogen (NEOG) | United States | $2.380B | 52.10 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.213B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.39 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.35 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |